RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients.
2006-01-01 Scandurra, G; Ferraro, Giuseppa; Franchina, Tindara; Chiofalo, G; Zanghi', Mariangela; Festa, V; Pastura, G; Adamo, Vincenzo
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER
2001-01-01 Adamo, Vincenzo; Scimone, A.; DE VINCENZO, F.; D'Angelo, A.; Ferraro, Giuseppa; Altavilla, Giuseppe; Garipoli, Claudia; Zanghi', Mariangela
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis.
2010-01-01 Franchina, Tindara; Adamo, Barbara; Caristi, Nicola; G., Chiofalo; G., Toscano; Colonese, Francesca; Denaro, Nerina; Ricciardi, GIUSEPPINA ROSARIA; A., Russo; Adamo, Vincenzo; University, Polyclinic; Messina, Italy; School of, Medicine; University, Polyclinic; Palermo, Italy
Activity and tolerability of cisplatin (CDDP) and fotemustine (FTM) in non-small cell lung cancer (NSCLC) patients (PTS) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
2009-01-01 D., Galetta; V., Gebbia; F., Ferraù; F., Carrozza; S., Cigolari; P., Russo; F., Calista; Adamo, Vincenzo; G., Colucci
An immunohistochemical investigation of pre-metastatic niche (PMN) in node-negative invasive breast carcinomas
2010-01-01 Ieni, Antonio; Simone, Angela; Giuffre', Giuseppe; Grosso, Maddalena; Scarfi', Rosa; F. M., Plutino; Colonese, Francesca; Adamo, Vincenzo; Tuccari, Giovanni
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC).
2013-01-01 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo
Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study.
2017-01-01 Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V
Correlation between biological agent-based regimens as first line treatment and outcomes in patients with KRAS wild type metastatic colorectal cancer (mCRC).
2013-01-01 Chiofalo, G; Toscano, G; Berenato, R; Smiroldo, V; Noto, L; Proto, C; Buda, Carmelo; Giuffre', Giuseppe; Adamo, Vincenzo
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation.
2013-01-01 Ferraro, Giuseppa; Proto, C; Del Re, C; Agostino, R; Zanghi', Mariangela; Buda, Carmelo; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Vincenzo
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib:
2011-01-01 Franchina, Tindara; Proto, C; Noto, L; Chiofalo, G; Ferraro, Giuseppa; Picciotto, Maria; Adamo, Vincenzo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. | 1-gen-2006 | Scandurra, G; Ferraro, Giuseppa; Franchina, Tindara; Chiofalo, G; Zanghi', Mariangela; Festa, V; Pastura, G; Adamo, Vincenzo | |
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER | 1-gen-2001 | Adamo, Vincenzo; Scimone, A.; DE VINCENZO, F.; D'Angelo, A.; Ferraro, Giuseppa; Altavilla, Giuseppe; Garipoli, Claudia; Zanghi', Mariangela | |
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis. | 1-gen-2010 | Franchina, Tindara; Adamo, Barbara; Caristi, Nicola; G., Chiofalo; G., Toscano; Colonese, Francesca; Denaro, Nerina; Ricciardi, GIUSEPPINA ROSARIA; A., Russo; Adamo, Vincenzo; University, Polyclinic; Messina, Italy; School of, Medicine; University, Polyclinic; Palermo, Italy | |
Activity and tolerability of cisplatin (CDDP) and fotemustine (FTM) in non-small cell lung cancer (NSCLC) patients (PTS) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM). | 1-gen-2009 | D., Galetta; V., Gebbia; F., Ferraù; F., Carrozza; S., Cigolari; P., Russo; F., Calista; Adamo, Vincenzo; G., Colucci | |
An immunohistochemical investigation of pre-metastatic niche (PMN) in node-negative invasive breast carcinomas | 1-gen-2010 | Ieni, Antonio; Simone, Angela; Giuffre', Giuseppe; Grosso, Maddalena; Scarfi', Rosa; F. M., Plutino; Colonese, Francesca; Adamo, Vincenzo; Tuccari, Giovanni | |
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). | 1-gen-2013 | Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo | |
Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study. | 1-gen-2017 | Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V | |
Correlation between biological agent-based regimens as first line treatment and outcomes in patients with KRAS wild type metastatic colorectal cancer (mCRC). | 1-gen-2013 | Chiofalo, G; Toscano, G; Berenato, R; Smiroldo, V; Noto, L; Proto, C; Buda, Carmelo; Giuffre', Giuseppe; Adamo, Vincenzo | |
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. | 1-gen-2013 | Ferraro, Giuseppa; Proto, C; Del Re, C; Agostino, R; Zanghi', Mariangela; Buda, Carmelo; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Vincenzo | |
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: | 1-gen-2011 | Franchina, Tindara; Proto, C; Noto, L; Chiofalo, G; Ferraro, Giuseppa; Picciotto, Maria; Adamo, Vincenzo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 14.a Contributo in Rivista 76
- 14.a Contributo in Rivista::14.a.... 76
Data di pubblicazione
- 2010 - 2017 35
- 2000 - 2009 40
- 1991 - 1999 1
Editore
- Elsevier 1
Rivista
- ANNALS OF ONCOLOGY 27
- JOURNAL OF CLINICAL ONCOLOGY 20
- TUMORI 8
- PATHOLOGICA 6
- JOURNAL OF THORACIC ONCOLOGY 3
- EUROPEAN JOURNAL OF CANCER 2
- JOURNAL OF ONCOLOGY 2
- TUMORI 2
- BMC GERIATRICS 1
- CANCER RESEARCH 1
Keyword
- Breast cancer Lymph node Meta... 1
Lingua
- eng 48
Accesso al fulltext
- no fulltext 75
- restricted 1